Gland Pharma Limited IPO
Mainboard₹15000 / 10 Shares
IPO Live Subscription Details
| Category | Subscription (Times) |
|---|---|
| Date | 2020-11-11 17:00:00 |
| QIBs | 6.40 |
| NII | 0.51 |
| Retail | 0.24 times |
| Total | 2.06 times |
Gland Pharma Limited IPO Details
The Gland Pharma Limited IPO price band is set between ₹1490 - 1500 per equity share, with a face value of ₹1 per share. The issue is managed by Link Intime India Private Ltd, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 9 Nov, 2020 and closes on 11 Nov, 2020. Investors can check the allotment status on 18 Nov, 2020, while the listing date is tentatively scheduled for 20 Nov, 2020.
The total issue size is 43,196,968 Eq Shares of ₹1 , aggregating up to ₹6,479.55 Cr. Stay tuned for the latest Gland Pharma Limited IPO review and GMP updates.
Gland Pharma Limited IPO Review, Rating & Analysis
Gland Pharma Limited IPO Review
NO REVIEWGland Pharma Limited IPO Rating
Gland Pharma Limited IPO Highlights
IPO Date
Nov 9, 2020 - Nov 11, 2020
Listing Date
20 Nov, 2020
Face Value
₹1 Per Equity Share
Price Band
₹1490 - 1500 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE, NSE
Gland Pharma Limited IPO Lot Size
The minimum market lot for Gland Pharma Limited IPO is 10 shares with an application amount of ₹15,000. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 10 | ₹15,000 |
| Retail (Max) | 13 | 130 | ₹1,95,000 |
| S-HNI (Min) | 14 | 140 | ₹2,10,000 |
| S-HNI (Max) | 66 | 660 | ₹9,90,000 |
| B-HNI (Min) | 67 | 670 | ₹10,05,000 |
Gland Pharma Limited IPO Timeline
Issue Price
₹1490 - 1500 per equity shareFace Value
₹1 Per Equity ShareListing at Group
BSE, NSERegistrar
Link Intime India Private LtdLead Manager
Citigroup Global Markets India Private LimitedHaitong Securities India Private LimitedKotak Mahindra Capital Company LimitedNomura Financial Advisory And Securities (India) Pvt LtdIssue Size
43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr)Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr)Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr)Gland Pharma Limited IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 20 | 4086.03 | 2772.40 | 772.85 | - | - | - |
| 31 Mar 19 | 3523.54 | 2129.76 | 451.85 | - | - | - |
| 31 Mar 18 | 2.929.46 | 1671.68 | 321.05 | - | - | - |
All values are in ₹ Cr.
Promoters & Share Holding
Promoter(s) Name
- Fosun Pharma Industrial Pte. Ltd
- Shanghai Fosun Pharmaceutical (Group) Co. Ltd
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| N/A | N/A |
About Company
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.
They operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped them witness exponential growth.
They are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Gland Pharma Limited IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 8,639,394 | 6,479,546 | 15,118,939 | 27,350,957 |
Day 1 -09-11-20 05:00 PM | 0.00 x | 0.01 | 0.08 x | 0.05 x |
Day 2 -10-11-20 05:00 PM | 0.48 x | 0.03 | 0.15 x | 0.22 x |
Day 3 -11-11-20 06:00 PM | 6.40 x | 0.51 | 0.24 x | 2.06 x |
Frequently Asked Questions about Gland Pharma Limited IPO IPO
When will Gland Pharma Limited IPO open for subscription?
The Gland Pharma Limited IPO opens on 9 Nov, 2020 and closes on 11 Nov, 2020.
What is the investors portion for Gland Pharma Limited IPO?
The investors' portion for QIB is 6.40 x, NII is 0.51, and Retail is 0.24 x.
How to apply for Gland Pharma Limited IPO?
You can apply for Gland Pharma Limited IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Gland Pharma Limited IPO?
The issue size of Gland Pharma Limited IPO is approx ₹43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr)Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr)Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr) crores.
What is the price band of Gland Pharma Limited IPO?
The price band for Gland Pharma Limited IPO is ₹1490 to ₹ 1500 per equity share.
What is the lot size of Gland Pharma Limited IPO?
The minimum bid (lot size) for Gland Pharma Limited IPO is N/A shares with an investment of approx ₹15000 .
What is the allotment date of Gland Pharma Limited IPO?
The allotment date for Gland Pharma Limited IPO is 18 Nov, 2020.
What is the listing date of Gland Pharma Limited IPO?
The listing date for Gland Pharma Limited IPO is expected to be 20 Nov, 2020.
What is the GMP of Gland Pharma Limited IPO?
The latest Grey Market Premium (GMP) for Gland Pharma Limited IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.